Skip to Content

Betamethasone Topical Dosage

Applies to the following strength(s): benzoate 0.025% ; dipropionate 0.05% ; valerate 0.1% ; dipropionate 0.1% ; dipropionate, augmented 0.05% ; 0.12%

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

Cream, gel, ointment: Apply a thin film to the affected area once or twice a day
Foam, lotion: Apply twice a day (once in the morning and once at night)

Comments:
-Treatment should be limited to two weeks.
-Use should be limited to 45 g per week.
-This topical drug should not be used with occlusive dressings, unless directed by a healthcare provider.
-If an infection develops, appropriate antimicrobial therapy should be initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Dermatitis

12 years or older:
Cream, gel, ointment: Apply a thin film to the affected area once or twice a day.
Foam, lotion: Apply twice a day (once in the morning and once at night)

Comments:
-Treatment should be limited to two weeks.
-Use should be limited to 45 g per week.
-This topical drug should not be used with occlusive dressings, unless directed by a healthcare provider.
-If an infection develops, appropriate antimicrobial therapy should be initiated.

Use: Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Contact with the eyes should be avoided.
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.

Hide